• Every Microbiome Tells a Changeable, Computable Story

    Bio-IT World | People are not only human but also microbial, a summation largely of the choices they make: their social interactions, the food they eat, medications they take, their activity level, and daily habits. The microbes that are transmissible person-to-person are sometimes beneficial, but the odds are slightly better that they are causing harm.

    Jun 24, 2026

  • Notes from the Trenches: A Computational Biologist’s View of Drug Discovery’s Digital Revolution

    Bio-IT World | When Eleanor Howe took the stage at Bio-IT World Conference & Expo 2026 to deliver the annual “Trends from the Trenches” address, she arrived with a clear mandate: no buzzwords, no vendor spin, and no marketing varnish. She built this year’s Trends from the Trenches session from hours of interviews with colleagues, clients, and trusted advisors across the life sciences sector, delivering a wide-ranging, candid survey of where the field actually stands and what she predicts lies ahead.

    Jun 23, 2026

  • AI Readiness in Pharma – Getting the Foundation Right

    Bio-IT World | Many years ago, when AI was seen more in science fiction than in the real world, we were asked a seemingly simple question in an innovation workshop – why is it that our bank accounts and credit cards can be used globally, but we can’t do the same with our health information?

    Jun 18, 2026

  • AI Readiness in Pharma – Getting the Foundation Right

    Bio-IT World | Many years ago, when AI was seen more in science fiction than in the real world, we were asked a seemingly simple question in an innovation workshop – why is it that our bank accounts and credit cards can be used globally, but we can’t do the same with our health information?

    Jun 18, 2026

  • The Invisible Infrastructure: Bio-IT World Panel Warns of a Slow-Motion Crisis in Biomedical Data

    Bio-IT World | A group of researchers is sounding the alarm: the publicly funded data infrastructure underpinning virtually all of modern biomedical research is fragile, underfunded, and increasingly at risk. It is up to us to safeguard it. At a session at last month’s Bio-IT World Conference & Expo, Douaa Mugahid, PhD, Data Officer at the Hi-IMPAcTB Consortium at the Harvard School of Public Health moderated a panel of academics, investors, and consultants to take on the future of public data and software infrastructure.

    Jun 17, 2026